In an era of rapid development in pharmaceutical logistics, ensuring efficient and secure delivery of medical products remains a critical public health priority. The recent cooperation agreement between SF Holdings and Tonghua International Inland Port in Jilin province represents a proactive response to this challenge.
Under the newly signed agreement, SF Holdings will leverage Tonghua International Inland Port's comprehensive infrastructure and strategic geographical advantages to deepen collaboration across multiple areas including cold chain pharmaceutical distribution, warehouse management, and value-added services.
The inland port will provide SF with 1,500 square meters of warehouse and office space to support its pharmaceutical logistics network in the Tonghua region. Monitoring systems and necessary supporting equipment for the pharmaceutical warehouse have already been installed. Additionally, SF will deploy four specialized cold chain vehicles and corresponding operational tools, with full operations expected to commence within two weeks.
Tonghua City, home to numerous pharmaceutical enterprises, offers significant market potential for medical logistics. SF conducted thorough research of Tonghua International Inland Port last November, engaging in extensive discussions with local government departments including the Development and Reform Commission and Commerce Bureau, along with industry representatives.
This partnership positions SF to strengthen its market share in Jilin province while driving overall improvements in pharmaceutical logistics services. By utilizing Tonghua International Inland Port as a development platform, the company aims to explore more efficient cold chain solutions and enhance service quality and coverage.
Moving forward, Tonghua's Postal Administration will actively support the healthy development of SF's pharmaceutical logistics operations, helping to establish Tonghua as a "China Pharmaceutical City" brand and boost its national influence and competitiveness. This collaboration between SF Holdings and Tonghua International Inland Port marks a significant step forward for the future of pharmaceutical logistics.
